OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2025-12-31-accounts

THE FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE

ANNUAL REPORT AND AUDITED FINANCIAL STATEMENTS

YEAR ENDED 31 DECEMBER 2025

Charity No 264136

THE FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE ANNUAL REPORT AND FINANCIAL STATEMENTS YEAR ENDED 31 DECEMBER 2025

The Trust was established under a trust deed in April 1972 in order to provide relief to patients at the centre and to support the work of the centre.

The Trust is a registered charity.

President: The Lord Mayor of Bristol
Officers
Chair Olivia Grogono- until 12th November 2025
Jane Lockwood - from 12th November 2025
Treasurer CarolineOwen
Trustees Steve Blake
Elizabeth Cameron
Ann Carlton
Geoff Clements
Melinda Densham
Gillian Creese
Gillian Crichton
Jane Lockwood
Stephen Moorlen
Patricia Murphy
Caroline Owen
Elizabith Pritchard
Helen Sharp
Advisors
Bankers National Westminster Bank plc
Bristol City Office
Auditors Charlton Baker (Bristol) Limited
1st Floor 61 Macrae Road
Ham Green
Bristol
BS20 0DD
Stock brokers Alpha Portfolio Management
1 The Square
Temple Quay
Bristol
Registered Office Bristol Haematology and Oncology Centre
Horfield Road
Bristol
Telephone 0117 342 3432

Page 1

THE FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE ANNUAL REPORT AND FINANCIAL STATEMENTS YEAR ENDED 31 DECEMBER 2025

Trustees’ report

The trustees present their report and the audited financial statements for the year ended 31 December 2025.

The financial statements have been prepared in accordance with the Statement of Recommended Practice: Accounting and Reporting by Charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102) and the Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland (FRS102) and the Charities Act 2011 and UK Generally Accepted Practice as it applies from 1 January 2015

Constitution and objects

The Trust was constituted under the model deed for Friends of Hospitals. A revised constitution was adopted in September 2006. The principal object of the Trust as set out in the constitution is to offer relief to patients and former patients and to support the work of the Centre.

During the year, the charity’s main objectives continued to be those of fundraising and management of the investment portfolio, enabling financial support to be given to the Bristol Haematology and Oncology Centre in respect of specific projects.

The trustees confirm that they have referred to the guidance contained in the Charity Commissioners’ general guidance on public benefit when reviewing the Trust’s aims and objectives and in planning future funding of the Centre.

Structure and organization

The Trust is unincorporated and is a registered charity. The trustees in office during the year and at the date of this report are as set out on page 1.

A main committee as set out in the constitution manages the Trust. Meetings are held quarterly and are attended by representatives from the hospital. Trustees are invited to join the committee by existing trustees or by recommendations from hospital staff. In addition to the main committee there is an investment committee which has responsibility for investing the Trust's reserves.

The investment committee is chaired by Mrs J Lockwood. The following trustees also serve on the committee: Mr GJ Clements, and Mrs CM Owen.

Review of activities and future developments

During the year the Trust has continued to raise money to benefit the patients of The Bristol Haematology and Oncology Centre. The fundraising is largely carried out by volunteers and the trustees are very grateful to the many volunteers who carried out fund raising activities on behalf of the Trust during the year.

The Trust has, and will continue to, support the work of the hospital by financing various capital and research projects undertaken by the hospital and Bristol University.

Financial activities and affairs

There have been no changes in the policies of the Trust during the year.

During the year incoming resources from fundraising, donations and legacies and investment income totalled £254,170 (2024: £315,246), and expenditure on specific projects amounted to £369,183 (2024: £949,503). After deducting the charity’s operating expenses and allowing for the realised and unrealised investment revaluation surpluses the resulting surplus for the year was £337,039 (2024: deficit £368,070).

At the year end the Trust’s balance sheet showed total funds of £5,325,671 (2024: £4,988,632) of which £5,292,486 (2024: £4,961,402) were unrestricted funds.

Page 2

THE FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE ANNUAL REPORT AND FINANCIAL STATEMENTS YEAR ENDED 31 DECEMBER 2025

Reserves

The unrestricted fund represents the accumulated surpluses from previous years. The policy of the Trust is to build these reserves by judicious management of investment assets to maximise the income available for future years. The expenditure on charitable objectives each year depends on the requests from the hospital management. All expenditure is approved by the hospital management before being presented to the Trustees at quarterly meetings. The level of reserves is reviewed at the meetings and decisions regarding expenditure is made by the Trustees having given consideration to available reserves and funds already committed. The Trustees keep sufficient reserves to support any long term commitments to the hospital. Surplus reserves have been invested to maximise income and consequently investments are available to be realised should charitable expenditure exceed available cash in the bank.

The restricted funds represent funds held for specific purposes as set out in note 12 to the financial statements

Trustees’ responsibility for the accounts

Law applicable to charities in England and Wales requires the trustees to prepare financial statements for each financial year, which give a true and fair view of the financial activities of the charity during the year and of its state of affairs at the end of the year. In preparing those financial statements the trustees are required to:

  1. Select suitable accounting policies and apply them consistently;

  2. Make judgments and estimates that are reasonable and prudent;

  3. Observe the methods and principles in the Charities SORP

  4. State whether applicable accounting standards and statements of recommended practice have been followed, subject to any material departures disclosed and explained in the financial statements; and; 5. Prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Charity will continue in operation.

The trustees are responsible for keeping proper accounting records, which disclose with reasonable accuracy at any time the financial position of the charity and which enable them to ensure that the financial statements comply with section 130 of the Charities Act 2011 and general law. They are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Risk management

The trustees have assessed the major risks to which the Trust is exposed, in particular those related to the operations and finances of the Trust, and are satisfied that systems are in place to mitigate exposure to such risks.

Investment policy

The trustees have the power to invest in such assets as they see fit.

The investment committee meets at least three times a year to review the investment portfolio and the cash requirements of the Trust. For the last few years the Trust’s income has exceeded its requirements and as a result the investment strategy is to invest in low and medium risk investments to balance capital appreciation with a reasonable income flow to enable the trust to meet its objectives.

Approved by the trustees on 10th October 2026 and signed on their behalf by:

Mrs Caroline Owen

Trustee

Page 3

INDEPENDENT AUDITOR’S REPORT TO THE TRUSTEES OF THE FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE

Opinion

We have audited the financial statements of The Friends of Bristol Haematology and Oncology Centre (the “Charity”) for the year ended 31 December 2025 which comprise the Statement of Financial Activities, Balance Sheet, and notes to the financial statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102: The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion, the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor’s responsibilities for the audit of the financial statements section of our report. We are independent of the Charity in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

We have nothing to report in respect of the following matters in relation to which the ISAs (UK) require us to report to you where:

• the trustees’ use of the going concern basis of accounting in the preparation of the financial statements is not appropriate; or

• the trustees have not disclosed in the financial statements any identified material uncertainties that may cast significant doubt about the Charity’s ability to continue to adopt the going concern basis of accounting for a period of at least twelve months from the date when the financial statements are authorised for issue.

Other information

The trustees are responsible for the other information. The other information comprises the information included in the annual report other than the financial statements and our auditor’s report thereon. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the Charity and its environment obtained in the course of the audit, we have not identified material misstatements in the Trustees’ Annual Report.

Page 4

We have nothing to report in respect of the following matters in relation to which the Charities Act 2011 requires us to report to you if, in our opinion:

Responsibilities of the trustees

As explained more fully in the trustees’ responsibilities statement set out on page 3, the trustees are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as they determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the trustees are responsible for assessing the Charity’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the Charity or to cease operations, or have no realistic alternative but to do so.

Our responsibilities for the audit of the financial statements

Key audit matters: our assessment of risks of material misstatement

Key audit matters are those matters that in our professional judgement were of most significance in the audit of the financial statements and include the most significant assessed risks of material misstatement (whether or not due to fraud) identified by us, including those which had the greatest effect on the allocation of resources in the audit, and directing the efforts of the engagement team. There are no key areas identified as the audit is very low risk with normal audit procedures adequate in all audit areas.

We agreed to report to the board of trustees any corrected or uncorrected identified misstatements

Identifying and reporting of risks of material misstatement due to fraud

To identify risks of material misstatement due to fraud we assessed events or conditions that could indicate an incentive or pressure to commit fraud or provide an opportunity to commit fraud. Our risk assessment procedures included:

(i) enquiring of the trustees and inspection of key papers provided to those charged with governance as to high level policies and procedures to prevent and detect fraud.

(ii) reviewing the minutes of trustees' meetings.

We communicated identified fraud risks throughout the audit team and remained alert to any indications of fraud throughout the audit.

As required by Auditing Standards, and taking into account our overall knowledge of the control environment, we performed procedures to assess the risks of management override of controls. To address the pervasive risk as it related to management override of controls, we reviewed material journal entries and agreed these to supporting documentation where appropriate.

Identifying and responding to risks of material misstatement due to non-compliance with laws and regulations

We identified areas of laws and regulations that could reasonably be expected to have a material effect on the financial statements from our general commercial and sector experience and through discussion with the Treasurer. As the charity is regulated, our assessment of risks involved gaining an understanding of the control environment including the entity's procedures for complying with regulatory requirements.

Page 5

We communicated identified laws and regulations throughout our team and remained alert to any indications of non-compliance throughout the audit.

Auditing Standards limit the required audit procedures to identify non-compliance with these laws and regulations to enquiry of management and trustees and inspection of regulatory and legal correspondence, if any. Therefore, if any breach of operational regulations is not disclosed to us or evident from relevant correspondence, an audit will not detect that breach.

Limitations to the ability of the audit to detect fraud or breaches of laws and regulation

Owing to the inherent limitation of an audit, there is an unavoidable risk that we may not have detected some material misstatements in the financial statements, even though we have properly planned and performed our audit in accordance with auditing standards. For example, the further removed non-compliance with laws and regulations is from the events and transactions reflected in the financial statements, the less likely the inherently limited procedures required by Auditing Standards would identify it.

In addition, as with any audit, there remained a higher risk of non-detection of fraud, as this may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal controls. Our audit procedures are designed to detect material misstatement, and therefore we are not responsible for preventing non-compliance or fraud and cannot be expected to detect non-compliance with all laws and regulations.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council’s website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report.

Use of our report

This report is made solely to the Charity's trustees, as a body, in accordance with section 144 of the Charities Act 2011 and the regulations made under section 154 of that Act. Our audit work has been undertaken so that we might state to the Charity's trustees those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Charity's trustees as a body, for our audit work, for this report, or for the opinions we have formed.

Paul Cridland

Charlton Baker (Bristol) Ltd (Chartered Accountants and Statutory Auditor) 1[st] Floor, 61 Macrae Road

Eden Business Park

Ham Green Bristol BS20 0DD

Date 19th October 2026

Page 6

THE FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE STATEMENT OF FINANCIAL ACTIVITIES YEAR ENDED 31 DECEMBER 2025

Income and endowments
from
Donations and legacies
3
Other trading activities
4
Investment income
5
Total
Expenditure on
Raising funds
6
Charitable activities
7
Total
Net income
Transfers
Gross transfers between funds
Net income before other
recognised gains and
losses
OTHER RECOGNISED GAINS
(Losses)/gains on investments
Net movement in funds
Realised gains on disposals
Unrealised gains/(losses) on
revaluations
Total funds brought forward
Total funds carried forward
Note
Unrestricted
fund
£
116,712
1,972
94,755
213,439
2,640
182,321
184,961
28,478
(203,988)
(175,510)
96,287
410,307
331,084
4,961,402
5,292,486
Restricted
funds
£
40,709
-
22
40,731
-
238,764
238,764
(198,033)
203,988
5,955
-
-
5,955
27,230
33,185
2025
Total
£
157,421
1,972
94,777
254,170
2,640
421,085
423,725
(169,555)
-
(169,555)
96,287
410,307
337,039
4,988,632
5,325,671
Unrestricted
fund
£
143,052
44,852
108,521
296,425
20,035
98,112
118,147
178,278
(862,781)
(684,503)
60,804
275,287
(348,412)
5,309,814
4,961,402
Restricted
funds
£
18,564
-
257
18,821
-
901,260
901,260
(882,439)
862,781
(19,658)
-
-
(19,658)
46,888
27,230
2024
Total
£
161,616
44,852
108,778
315,246
20,035
999,372
1,019,407
(704,161)
-
(704,161)
60,804
275,287
(368,070)
5,356,702
4,988,632

All activities relate to continuing operations.

All gains and losses recognised in the year are included in the Statement of Financial Activities.

Page 7

THE FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE BALANCE SHEET YEAR ENDED 31 DECEMBER 2025

FIXED ASSETS
Investments
9
CURRENT ASSETS
Debtors
10
11
Net current assets
Total assets less current liabilities
Funds
12
Unrestricted fund
Restricted fund
Note
Cash at bank and in hand
CREDITORS: amounts falling due within one
year
£
£
5,308,252
2,215
50,692
52,907
35,488
17,419
5,325,671
5,292,486
33,185
5,325,671
2025
£
£
4,889,241
75,000
43,480
118,480
19,089
99,391
4,988,632
4,961,402
27,230
4,988,632
2024
£
£
4,889,241
75,000
43,480
118,480
19,089
99,391
4,988,632
4,961,402
27,230
4,988,632
2024
4,988,632
4,961,402
27,230
4,988,632

Approved and authorised for issue by the Trustees on 10th October 2026 and signed on their behalf by

Mrs J Lockwood - Chair

The notes on pages 10 to 15 form an integral part of these accounts.

Page 8

THE FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

1. Accounting policies

Basis of preparation and assessment of going concern

The financial statements have been prepared under the historical cost convention, as modified by the revaluation of certain fixed assets, and in accordance with the Statement of Recommended Practice 'Accounting and Reporting by Charities preparing their accounts in accordance with Financial Reporting Standard applicable in the UK and Republic of Ireland' (FRS102), applicable accounting standards and the Charities Act 2011.

The Trust constitutes a public benefit entity as defined by FRS102.

Incoming resources

Donations are accounted for when received by the Trust and legacies are recognised when it is probable that they will be received. Other income is accounted for on an accruals basis as far as it is prudent to do so. Income includes income tax recoverable.

Resources expended

Liabilities are recognised as soon as there is a legal or constructive obligation committing the charity to the expenditure. All expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all costs related to the category.

Charitable expenditure comprises those costs incurred by the charity in the delivery of its activities and services for its beneficiaries. It includes both costs that can be directly allocated to the activity and indirect costs required to support the work of the charity.

Gifts in kind

The Trust receives the benefit of work carried out by volunteers and is allocated a room at the Centre free of charge. No value is placed on these items.

Taxation

As a registered charity, the trust is exempt from tax as it has no taxable activities. Irrecoverable VAT borne by the Trust is included in the cost of the item to which it relates.

Investments

Investment income is taken into account on the basis of the due date of payment. Investments are a form of basic financial instrument and are initially recognised at their transaction value and subsequently measured at their fair value as at the balance sheet date using the closing quoted market price . All gains and losses, whether realised or unrealised are credited or charged to the Unrestricted Fund.

Fund accounting

Unrestricted income funds are general funds that are available for use at the Trustees' discretion in furtherance of the objectives of the charity.

Restricted funds are those donated for use in a particular area or for a specific purpose, the use of which is restricted to that area.

Details of the nature and purpose of each fund is set out in note 12.

Governance costs

Governance costs include costs of the preparation and examination of the Report and Financial Statement, costs relating to Trustees' meetings and any legal costs relating to governance and constitutional matters.

2. Transactions with Trustees and other connected persons

No transactions took place between the Trust and the Trustees or any persons connected with them.

Page 9

THE FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

3. Donations and legacies

Donations
Tax refunds
Legacies
Other activities to generate funds
Sale of merchandise
Events run by the trust
Investment income
Dividends from UK listed
investments
Interest receivable
Raising Funds
Purchase of items for sale
Fundraising costs
Cost of events run by the Trust
Unrestricted
fund
£
92,513
5,550
18,649
116,712
Unrestricted
fund
£
1,972
-
1,972
Unrestricted
fund
£
81,042
13,713
94,755
Unrestricted
fund
£
1,331
1,309
-
2,640
Restricted
fund
£
40,709
-
-
40,709
Restricted
fund
£
-
-
-
Restricted
fund
£
-
22
22
Restricted
fund
£
-
-
-
-
2025
2025
2025
2025
Total
£
133,222
5,550
18,649
157,421
Total
£
1,972
-
1,972
Total
£
81,042
13,735
94,777
Total
£
1,331
1,309
-
2,640
Unrestricted
fund
£
60,534
7,518
75,000
143,052
Unrestricted
fund
£
1,275
43,577
44,852
Unrestricted
fund
£
98,972
9,549
108,521
Unrestricted
fund
£
986
-
19,049
20,035
Restricted
fund
£
18,564
-
-
18,564
Restricted
fund
£
-
-
-
Restricted
fund
£
-
257
257
Restricted
fund
£
-
-
-
-
2024
2024
2024
2024
Total
£
79,098
7,518
75,000
161,616
Total
£
1,275
43,577
44,852
Total
£
98,972
9,806
108,778
Total
£
986
-
19,049
20,035

4. Other activities to generate funds

5. Investment income

6. Raising Funds

Page 10

THE FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

7. Details of Charitable Activities

Details of Charitable Activities
Grants and Donations
Equipment purchased
Research salaries
Nursing salaries
Patient therapy
Patient amenities
Courses training and library
Support costs
Insurance
Emoluments of employee
Stockbroker's fees
Social media
Office cost
Governance costs
Auditor's remuneration
Unrestricted
fund
£
-
81,026
20,369
16,888
2,984
9,152
664
11,483
27,796
4,686
1,463
5,810
182,321
Restricted
fund
£
237,611
-
-
-
1,153
-
-
-
-
-
-
238,764
2025
Total
£
237,611
81,026
20,369
16,888
4,137
9,152
664
11,483
27,796
4,686
1,463
5,810
421,085
Unrestricted
fund
£
-
15,613
-
18,000
5,405
9,225
624
11,069
27,097
4,230
1,779
5,070
98,112
Restricted
fund
£
821,632
77,758
-
-
1,870
-
-
-
-
-
-
901,260
2024
Total
£
821,632
93,371
-
18,000
7,275
9,225
624
11,069
27,097
4,230
1,779
5,070
999,372

8. Staff costs

Staff costs were as follows:

Charge for salaries from University Hospitals Bristol NHS Foundation Trust

2025 2024
£ £
11,483
11,069

There was one employee throughout the year who was employed by University Hospitals Bristol NHS Foundation Trust on our behalf. . This employee did not receive emoluments of more than £60,000.

No trustees have received any remuneration or reimbursed expenses during the year, nor did any trustee have a disclosable interest in any of the charity's transactions.

Page 11

THE FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

9. Fixed asset investments

Overseas Equity shares
UK Equity shares
Prpoperty Trust
Alternatives
Fixed interest bonds
Cash
Historical cost of listed investments
Market value:
At 31 December 2024
Additions
Disposals
Increase in value in year
Transfer to income
At 31 December 2025
Listed investments at market value
Listed
investments
£
4,583,095
464,779
(434,261)
410,307
-
5,023,920
2025
£
2,769,737
1,009,985
46,500
230,330
967,368
5,023,920
284,332
5,308,252
4,081,787
Cash
£
306,146
530,548
(464,779)
-
(87,583)
284,332
2024
£
2,516,423
932,414
47,700
197,100
889,458
4,583,095
306,146
4,889,241
4,051,271
Total
£
4,889,241
995,327
(899,040)
410,307
(87,583)
5,308,252

At 31 December 2025 there were three holdings with a market value in excess of 5% of the total value. A holding of S&P I shares 500 equal weight ETF had a market value of £317,336, a holding of S&P I shares 500 ETF had a market value of £497,086 and a holding of Vanguard FTSE Developed Fund ex UK had a market value of £565,940.

At 31 December 2024 there were two holdings with a market value in excess of 5% of the total value. A holding of S&P I shares had a market value of £512,213 and a holding of Vanguard FTSE Developed World had a market value of £498,474.

10.[Debtors]

Debtors
Prepaid expenses
Legacies due
2025
£
2,215
-
2,215
2024
£
-
75,000
75,000

11. Creditors: amounts falling due within one year

Accrued expenses
Unpaid invoices
2025
£
5,600
29,888
35,488
2024
£
4,800
14,289
19,089

Page 12

THE FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

12. Funds

At 31
December
2024
Incoming
resources
£
£
Restricted Funds
-
33,623
-
-
1,504
22
25,726
7,086
27,230
40,731
Unrestricted funds
4,961,402
720,033
4,988,632
760,764
13.
Investments
Current assets
14. Approved future funding
Courses for hospital staff
Information support and research salaries
TYA complimentary therapies
Auto outlining software
Bariatic trolley
ECG Picc Equipment
Picc room chair
Steev Phantom
Handling equipment
Breast gowns
Mvision auto outlining software
Ceiling mounted screens
MRT Monitors
Scalp cooling machines
Ariane Papillon
Surface guided radiotherapy
Chemo chairs
Small pieces of equipment
Decontamination monitor
Analysis of net assets between funds
Creditors due within one year
Equipment fund - to purchase and maintain
medical equipment
Research Fund- to fund research projects
At 31 December 2025 the trust had entered into the following funding commitments.
Marsden bequest- to fund research salaries
General fund
Earmarked fund- gifts for other purposes
Resources
expended
£
237,611
-
-
1,153
238,764
184,961
423,725
Unrestricted
Funds
£
5,308,252
19,722
(35,488)
5,292,486
Transfers
between
funds
£
203,988
-
-
-
203,988
(203,988)
-
Restricted
Funds
£
-
33,185
-
33,185
At 31
December
2025
£
-
-
1,526
31,659
33,185
5,292,486
5,325,671
Total Funds
2024
£
5,308,252
52,907
(35,488)
5,325,671
£
16,000
102,200
24,000
53,874
25,000
10,400
5,950
31,233
9,528
4,282
39,000
9,986
23,000
21,862
425,000
265,000
46,410
17,500
22,995

Page 13